[1]
Atakla, H.G. et al. 2021. Immunotherapy for Recurrent orthostatic cerebral hypo-perfusion syndrome in recurrent COVID-19 infection. Nepal Journal of Neuroscience. 18, 2 (Jun. 2021), 64–66. DOI:https://doi.org/10.3126/njn.v18i2.35516.